20
Centaur Pharmaceuticals Private Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is PINDOLOL USP, with a corresponding US DMF Number 31622.
Remarkably, this DMF maintains an Active status since its submission on April 07, 2017, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of June 01, 2017, and payment made on April 28, 2017, indicating their dedication to facilitating drug approvals, Categorized as Type II